Growth Failure in Pediatric CKD: Why It Matters and What Helps

Why kidneys control height

Growth is a metabolic program, and CKD breaks it at every level: uremic toxins suppress appetite (calorie deficit is the biggest driver), the kidneys fail to excrete acid (acidosis steals bone), anemia reduces oxygen delivery, and uremia blunts growth hormone signaling. The result: children fall off growth curves early — often before other signs.

That's why the growth chart is the pediatric nephrologist's first read: height velocity is a continuous, cheap, early monitor of disease control.

The treatment ladder

Nutrition is step one and non-negotiable: high-calorie, high-protein plans adjusted for the CKD stage, with tube feeds (nasogastric or gastrostomy) when appetite can't meet targets — this alone restores growth in many children. Step two: correct acidosis (bicarbonate), treat anemia (iron, ESA), and manage mineral metabolism.

Step three — growth hormone: recombinant human GH is approved and effective in pediatric CKD, with growth velocity gains that persist; it works before dialysis, during dialysis, and its effect is greatest when started early with good nutrition.

The transplant effect

Transplant is the definitive growth treatment: graft function normalizes the hormonal and metabolic environment, and children typically show catch-up growth — most dramatically when transplanted before puberty. The strategy, then: protect growth with nutrition and GH while waiting, and time the transplant to maximize the pubertal growth spurt.